Asymptomatic Hyperuricemia: Risk Factors for the Development and Progression of Chronic Kidney Disease

被引：1

作者：

Kaelsch, Anna-Isabelle ^{[1
]}

Krueger, Bernd ^{[2
]}

机构：

[1] Univ Klinikum Mannheim, Med Klin 5, Mannheim, Germany

[2] Univ Klinikum Mannheim, Med Klin 5, Transplantat Zentrum Mannheim, Mannheim, Germany

来源：

DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT | 2017年 / 142卷 / 20期

关键词：

URIC-ACID; LOWERING THERAPY; RENAL OUTCOMES; METAANALYSIS; FEBUXOSTAT; DECLINE; COHORT; TRIAL; CKD;

D O I：

10.1055/s-0043-116919

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

[No abstract available]

引用

页码：1526 / 1529

页数：4

共 14 条

[1] Effects of uric acid-lowering therapy on renal outcomes: a systematic review and meta-analysis [J].

Bose, Bhadran ;

Badve, Sunil V. ;

Hiremath, Swapnil S. ;

Boudville, Neil ;

Brown, Fiona G. ;

Cass, Alan ;

de Zoysa, Janak R. ;

Fassett, Robert G. ;

Faull, Randall ;

Harris, David C. ;

Hawley, Carmel M. ;

Kanellis, John ;

Palmer, Suetonia C. ;

Perkovic, Vlado ;

Pascoe, Elaine M. ;

Rangan, Gopala K. ;

Walker, Robert J. ;

Walters, Giles ;

Johnson, David W. .

NEPHROLOGY DIALYSIS TRANSPLANTATION, 2014, 29 (02) :406-413

[2] Risk Factors of Hyperuricemia After Renal Transplantation and Its Long-term Effects on Graft Functions [J].

Eyupoglu, S. ;

Eyupoglu, D. ;

Kendi-Celebi, Z. ;

Akturk, S. ;

Tuzuner, A. ;

Keven, K. ;

Sengul, S. .

TRANSPLANTATION PROCEEDINGS, 2017, 49 (03) :505-508

[3] Allopurinol and Progression of CKD and Cardiovascular Events: Long-term Follow-up of a Randomized Clinical Trial [J].

Goicoechea, Marian ;

Garcia de Vinuesa, Soledad ;

Verdalles, Ursula ;

Verde, Eduardo ;

Macias, Nicolas ;

Santos, Alba ;

Perez de Jose, Ana ;

Cedeno, Santiago ;

Linares, Tania ;

Luno, Jose .

AMERICAN JOURNAL OF KIDNEY DISEASES, 2015, 65 (04) :543-549

[4] Early onset hyperuricemia is a prognostic marker for kidney graft failure: Propensity score matching analysis in a Korean multicenter cohort [J].

Han, Miyeun ;

Lee, Jung Pyo ;

Park, Seokwoo ;

Kim, Yunmi ;

Kim, Yong Chul ;

Ahn, Curie ;

Han, Duck Jong ;

Ha, Jongwon ;

Jung, In Mok ;

Lim, Chun Soo ;

Kim, Yon Su ;

Kim, Young Hoon ;

Oh, Yun Kyu .

PLOS ONE, 2017, 12 (05)

[5] Urate lowering therapy to improve renal outcomes in patients with chronic kidney disease: systematic review and meta-analysis [J].

Kanji, Tahir ;

Gandhi, Mandark ;

Clase, Catherine M. ;

Yang, Robert .

BMC NEPHROLOGY, 2015, 16

[6]

Kuwabara M, 2017, HYPERTENSION, V69, P1036, DOI [10.1161/HYPERTENSIONAHA.116.08998, 10.1161/hypertensionaha.116.08998]

[7] Is hyperuricemia an independent risk factor for new-onset chronic kidney disease?: a systematic review and meta-analysis based on observational cohort studies [J].

Li, Ling ;

Yang, Chen ;

Zhao, Yuliang ;

Zeng, Xiaoxi ;

Liu, Fang ;

Fu, Ping .

BMC NEPHROLOGY, 2014, 15

[8] Management of Chronic Kidney Disease: The Relationship Between Serum Uric Acid and Development of Nephropathy [J].

Mende, Christian .

ADVANCES IN THERAPY, 2015, 32 (12) :1177-1191

[9] Uric acid is not associated with decline in renal function or time to renal replacement therapy initiation in a referred cohort of patients with Stage III, IV and V chronic kidney disease [J].

Nacak, Hakan ;

van Diepen, Merel ;

Qureshi, Abdul R. ;

Carrero, Juan J. ;

Stijnen, Theo ;

Dekker, Friedo W. ;

Evans, Marie .

NEPHROLOGY DIALYSIS TRANSPLANTATION, 2015, 30 (12) :2039-2045

[10] Impact of Febuxostat on Renal Function in Gout Patients With Moderate-to-Severe Renal Impairment [J].

Saag, Kenneth G. ;

Whelton, Andrew ;

Becker, Michael A. ;

MacDonald, Patricia ;

Hunt, Barbara ;

Gunawardhana, Lhanoo .

ARTHRITIS & RHEUMATOLOGY, 2016, 68 (08) :2035-2043

← 1 2 →